No phaseActive, not recruitingAge-related condition
The NORwegian Atrial Fibrillation Self-SCREENing (NORSCREEN)
- Sponsor
- Oslo University Hospital (Academic or other)
- Enrollment
- 50,000 enrolled
- Conditions
- Atrial Fibrillation
- Interventions
- Long-term continuous ECG monitoring
- Ages
- older adults
- Registry
- NCT05914883
Full record on ClinicalTrials.gov
From the registry
Atrial fibrillation (AF) is common, increases the risk of mortality, stroke and heart failure, and portending significant burden to patients, societal health and health economy. One of three AF cases are undiagnosed. Several methods for detection of AF exist, but most of them have major limitations and are associated with resource-demanding diagnostic workup in the speciality health care services.
Primary outcomes
- Stroke
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered
Papers citing this trial
- Digital recruitment and prevalence of screen-detected atrial fibrillation in nationwide patch-based ECG screening: the NORSCREEN randomized clinical trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
- Cardiac-related symptoms in individuals aged ≥65 years without diagnosed cardiac disease: insights from the NORSCREEN trial
European heart journal open